Will leptin become the treatment of choice for functional hypothalamic amenorrhea?
Welt
Corrine K
CK
Reproductive Endocrine Unit, BHX 511, Massachusetts General Hospital, Boston, MA 02114, USA. cwelt@partners.org
D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D004958:Estradiol / Q000378:metabolism; D005260:Female; D006801:Humans; D007027:Hypothalamic Diseases / Q000150:complications*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D020738:Leptin / Q000627:therapeutic use*; D044342:Malnutrition / Q000503:physiopathology; D005082:Physical Exertion / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D015431:Weight Loss / Q000502:physiology
D020738:Leptin; D004958:Estradiol